The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hypertension RDN Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2029
Synopsis
The global Hypertension RDN Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Renal denervation (also called renal ablation) is a minimally invasive, investigational procedure to treat hypertension (high blood pressure) that hasn't improved with other treatments. This type of hypertension is called resistant hypertension
This report is a detailed and comprehensive analysis for global Hypertension RDN Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Hypertension RDN Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Hypertension RDN Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Hypertension RDN Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Hypertension RDN Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hypertension RDN Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hypertension RDN Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, ReCor Medical, Sonivies, Covidien and Boston Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Hypertension RDN Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
r-Renal Denervation(rRDN)
u-Renal Denervation(uRDN)
Market segment by Application
Hospital
Clinic
Others
Market segment by players, this report covers
Medtronic
ReCor Medical
Sonivies
Covidien
Boston Scientific
Johnson & Johnson
Terumo Corporation
Angiocare
Shanghai Golden Leaf Med Tec
Shanghai Bio-Heart Biological Technology
Xinmai Medical Equipment
Microport Ep Medtech
Cryofocus Medtech
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Hypertension RDN Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hypertension RDN Therapy, with revenue, gross margin and global market share of Hypertension RDN Therapy from 2018 to 2023.
Chapter 3, the Hypertension RDN Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Hypertension RDN Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Hypertension RDN Therapy.
Chapter 13, to describe Hypertension RDN Therapy research findings and conclusion.
The global Hypertension RDN Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Renal denervation (also called renal ablation) is a minimally invasive, investigational procedure to treat hypertension (high blood pressure) that hasn't improved with other treatments. This type of hypertension is called resistant hypertension
This report is a detailed and comprehensive analysis for global Hypertension RDN Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Hypertension RDN Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Hypertension RDN Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Hypertension RDN Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Hypertension RDN Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hypertension RDN Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hypertension RDN Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, ReCor Medical, Sonivies, Covidien and Boston Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Hypertension RDN Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
r-Renal Denervation(rRDN)
u-Renal Denervation(uRDN)
Market segment by Application
Hospital
Clinic
Others
Market segment by players, this report covers
Medtronic
ReCor Medical
Sonivies
Covidien
Boston Scientific
Johnson & Johnson
Terumo Corporation
Angiocare
Shanghai Golden Leaf Med Tec
Shanghai Bio-Heart Biological Technology
Xinmai Medical Equipment
Microport Ep Medtech
Cryofocus Medtech
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Hypertension RDN Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hypertension RDN Therapy, with revenue, gross margin and global market share of Hypertension RDN Therapy from 2018 to 2023.
Chapter 3, the Hypertension RDN Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Hypertension RDN Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Hypertension RDN Therapy.
Chapter 13, to describe Hypertension RDN Therapy research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of Hypertension RDN Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Hypertension RDN Therapy by Type
1.3.1 Overview: Global Hypertension RDN Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Hypertension RDN Therapy Consumption Value Market Share by Type in 2022
1.3.3 r-Renal Denervation(rRDN)
1.3.4 u-Renal Denervation(uRDN)
1.4 Global Hypertension RDN Therapy Market by Application
1.4.1 Overview: Global Hypertension RDN Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Hypertension RDN Therapy Market Size & Forecast
1.6 Global Hypertension RDN Therapy Market Size and Forecast by Region
1.6.1 Global Hypertension RDN Therapy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Hypertension RDN Therapy Market Size by Region, (2018-2029)
1.6.3 North America Hypertension RDN Therapy Market Size and Prospect (2018-2029)
1.6.4 Europe Hypertension RDN Therapy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Hypertension RDN Therapy Market Size and Prospect (2018-2029)
1.6.6 South America Hypertension RDN Therapy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Hypertension RDN Therapy Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Hypertension RDN Therapy Product and Solutions
2.1.4 Medtronic Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Medtronic Recent Developments and Future Plans
2.2 ReCor Medical
2.2.1 ReCor Medical Details
2.2.2 ReCor Medical Major Business
2.2.3 ReCor Medical Hypertension RDN Therapy Product and Solutions
2.2.4 ReCor Medical Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 ReCor Medical Recent Developments and Future Plans
2.3 Sonivies
2.3.1 Sonivies Details
2.3.2 Sonivies Major Business
2.3.3 Sonivies Hypertension RDN Therapy Product and Solutions
2.3.4 Sonivies Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sonivies Recent Developments and Future Plans
2.4 Covidien
2.4.1 Covidien Details
2.4.2 Covidien Major Business
2.4.3 Covidien Hypertension RDN Therapy Product and Solutions
2.4.4 Covidien Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Covidien Recent Developments and Future Plans
2.5 Boston Scientific
2.5.1 Boston Scientific Details
2.5.2 Boston Scientific Major Business
2.5.3 Boston Scientific Hypertension RDN Therapy Product and Solutions
2.5.4 Boston Scientific Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Boston Scientific Recent Developments and Future Plans
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Hypertension RDN Therapy Product and Solutions
2.6.4 Johnson & Johnson Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Johnson & Johnson Recent Developments and Future Plans
2.7 Terumo Corporation
2.7.1 Terumo Corporation Details
2.7.2 Terumo Corporation Major Business
2.7.3 Terumo Corporation Hypertension RDN Therapy Product and Solutions
2.7.4 Terumo Corporation Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Terumo Corporation Recent Developments and Future Plans
2.8 Angiocare
2.8.1 Angiocare Details
2.8.2 Angiocare Major Business
2.8.3 Angiocare Hypertension RDN Therapy Product and Solutions
2.8.4 Angiocare Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Angiocare Recent Developments and Future Plans
2.9 Shanghai Golden Leaf Med Tec
2.9.1 Shanghai Golden Leaf Med Tec Details
2.9.2 Shanghai Golden Leaf Med Tec Major Business
2.9.3 Shanghai Golden Leaf Med Tec Hypertension RDN Therapy Product and Solutions
2.9.4 Shanghai Golden Leaf Med Tec Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Shanghai Golden Leaf Med Tec Recent Developments and Future Plans
2.10 Shanghai Bio-Heart Biological Technology
2.10.1 Shanghai Bio-Heart Biological Technology Details
2.10.2 Shanghai Bio-Heart Biological Technology Major Business
2.10.3 Shanghai Bio-Heart Biological Technology Hypertension RDN Therapy Product and Solutions
2.10.4 Shanghai Bio-Heart Biological Technology Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Shanghai Bio-Heart Biological Technology Recent Developments and Future Plans
2.11 Xinmai Medical Equipment
2.11.1 Xinmai Medical Equipment Details
2.11.2 Xinmai Medical Equipment Major Business
2.11.3 Xinmai Medical Equipment Hypertension RDN Therapy Product and Solutions
2.11.4 Xinmai Medical Equipment Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Xinmai Medical Equipment Recent Developments and Future Plans
2.12 Microport Ep Medtech
2.12.1 Microport Ep Medtech Details
2.12.2 Microport Ep Medtech Major Business
2.12.3 Microport Ep Medtech Hypertension RDN Therapy Product and Solutions
2.12.4 Microport Ep Medtech Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Microport Ep Medtech Recent Developments and Future Plans
2.13 Cryofocus Medtech
2.13.1 Cryofocus Medtech Details
2.13.2 Cryofocus Medtech Major Business
2.13.3 Cryofocus Medtech Hypertension RDN Therapy Product and Solutions
2.13.4 Cryofocus Medtech Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Cryofocus Medtech Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Hypertension RDN Therapy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Hypertension RDN Therapy by Company Revenue
3.2.2 Top 3 Hypertension RDN Therapy Players Market Share in 2022
3.2.3 Top 6 Hypertension RDN Therapy Players Market Share in 2022
3.3 Hypertension RDN Therapy Market: Overall Company Footprint Analysis
3.3.1 Hypertension RDN Therapy Market: Region Footprint
3.3.2 Hypertension RDN Therapy Market: Company Product Type Footprint
3.3.3 Hypertension RDN Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Hypertension RDN Therapy Consumption Value and Market Share by Type (2018-2023)
4.2 Global Hypertension RDN Therapy Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Hypertension RDN Therapy Consumption Value Market Share by Application (2018-2023)
5.2 Global Hypertension RDN Therapy Market Forecast by Application (2024-2029)
6 North America
6.1 North America Hypertension RDN Therapy Consumption Value by Type (2018-2029)
6.2 North America Hypertension RDN Therapy Consumption Value by Application (2018-2029)
6.3 North America Hypertension RDN Therapy Market Size by Country
6.3.1 North America Hypertension RDN Therapy Consumption Value by Country (2018-2029)
6.3.2 United States Hypertension RDN Therapy Market Size and Forecast (2018-2029)
6.3.3 Canada Hypertension RDN Therapy Market Size and Forecast (2018-2029)
6.3.4 Mexico Hypertension RDN Therapy Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Hypertension RDN Therapy Consumption Value by Type (2018-2029)
7.2 Europe Hypertension RDN Therapy Consumption Value by Application (2018-2029)
7.3 Europe Hypertension RDN Therapy Market Size by Country
7.3.1 Europe Hypertension RDN Therapy Consumption Value by Country (2018-2029)
7.3.2 Germany Hypertension RDN Therapy Market Size and Forecast (2018-2029)
7.3.3 France Hypertension RDN Therapy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Hypertension RDN Therapy Market Size and Forecast (2018-2029)
7.3.5 Russia Hypertension RDN Therapy Market Size and Forecast (2018-2029)
7.3.6 Italy Hypertension RDN Therapy Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Hypertension RDN Therapy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Hypertension RDN Therapy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Hypertension RDN Therapy Market Size by Region
8.3.1 Asia-Pacific Hypertension RDN Therapy Consumption Value by Region (2018-2029)
8.3.2 China Hypertension RDN Therapy Market Size and Forecast (2018-2029)
8.3.3 Japan Hypertension RDN Therapy Market Size and Forecast (2018-2029)
8.3.4 South Korea Hypertension RDN Therapy Market Size and Forecast (2018-2029)
8.3.5 India Hypertension RDN Therapy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Hypertension RDN Therapy Market Size and Forecast (2018-2029)
8.3.7 Australia Hypertension RDN Therapy Market Size and Forecast (2018-2029)
9 South America
9.1 South America Hypertension RDN Therapy Consumption Value by Type (2018-2029)
9.2 South America Hypertension RDN Therapy Consumption Value by Application (2018-2029)
9.3 South America Hypertension RDN Therapy Market Size by Country
9.3.1 South America Hypertension RDN Therapy Consumption Value by Country (2018-2029)
9.3.2 Brazil Hypertension RDN Therapy Market Size and Forecast (2018-2029)
9.3.3 Argentina Hypertension RDN Therapy Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Hypertension RDN Therapy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Hypertension RDN Therapy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Hypertension RDN Therapy Market Size by Country
10.3.1 Middle East & Africa Hypertension RDN Therapy Consumption Value by Country (2018-2029)
10.3.2 Turkey Hypertension RDN Therapy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Hypertension RDN Therapy Market Size and Forecast (2018-2029)
10.3.4 UAE Hypertension RDN Therapy Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Hypertension RDN Therapy Market Drivers
11.2 Hypertension RDN Therapy Market Restraints
11.3 Hypertension RDN Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Hypertension RDN Therapy Industry Chain
12.2 Hypertension RDN Therapy Upstream Analysis
12.3 Hypertension RDN Therapy Midstream Analysis
12.4 Hypertension RDN Therapy Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
